Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 1—January 2006
Dispatch

Neutralizing Antibodies in Survivors of Sin Nombre and Andes Hantavirus Infection

Francisca Valdivieso*, Pablo Vial*, Marcela Ferres†, Chunyan Ye‡, Diane Goade‡, Analia Cuiza*, and Brian Hjelle‡§Comments to Author 
Author affiliations: *Universidad del Desarrollo, Santiago, Chile; †Pontifica Universidad Catolica de Chile, Santiago, Chile; ‡University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA; §TriCore Reference Laboratory, Albuquerque, New Mexico USA

Main Article

Table

Neutralizing antibody (NAb) titers against Andes virus (AND) and Sin Nombre virus (SNV) in survivors of hantavirus infection from Chile and the United States

Patient Origin Years after infection AND NAb titer SNV NAb titer
1 Chile 3 >1:1,600 1:100
2 Chile 4 1:400 <1:100
3 Chile 7 >1:1,600 <1:100
4 Chile 0.7 1:400 <1:100
5 Chile 4 1:400 <1:100
6 Chile 1 1:400 <1:100
7 Chile 4 1:800 1:100
8 Chile 3 1:200 <1:100
9 Chile 4 >1:1,600 <1:100
10 Chile 7 1:400 <1:100
11 Chile 1 1:400 <1:100
12 USA 1 <1:100 1:800
13 USA 3 <1:100 1:400
14 USA 4 <1:100 1:400
15 USA 4 1:100 >1:1,600
16 USA 3 <1:100 1:400
17 USA 5 <1:100 >1:1,600
18 USA 11 <1:100 1:400
19 USA 6 <1:100 1:800
20 USA 4 <1:100 >1:1,600

Main Article

Page created: February 21, 2012
Page updated: February 21, 2012
Page reviewed: February 21, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external